Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma. - Wikidata - wikimedia - TriplyDB

Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma.

Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma.

http://www.wikidata.org/entity/Q37126620

about

Therapeutic Targeting of Telomerase Anti-Cancer Stem-like Cell Compounds in Clinical Development - An Overview and Critical Appraisal Immunotherapy for cancer in the central nervous system: Current and future directions Direct Delivery of Antigens to Dendritic Cells via Antibodies Specific for Endocytic Receptors as a Promising Strategy for Future Therapies Overview of current immunotherapeutic strategies for glioma Immune responses to human cancer stem-like cells/cancer-initiating cells Whole Tumor Antigen Vaccines: Where Are We?Recombinant messenger RNA technology and its application in cancer immunotherapy, transcript replacement therapies, pluripotent stem cell induction, and beyond Immunotherapy for primary brain tumors: no longer a matter of privilege Immunotargeting of cancer stem cells Trial watch: Dendritic cell-based anticancer therapy Brain tissue banking for stem cells for our future DCVax®-L--developed by Northwest Biotherapeutics The notorious R.N.A. in the spotlight - drug or target for the treatment of disease Targeting specificity of dendritic cells on breast cancer stem cells: in vitro and in vivo evaluations.The future of high-grade glioma: Where we are and where are we going.Dendritic cells loaded with pancreatic Cancer Stem Cells (CSCs) lysates induce antitumor immune killing effect in vitro The transcription factor MITF is a critical regulator of GPNMB expression in dendritic cells.Prophylactic Dendritic Cell-Based Vaccines Efficiently Inhibit Metastases in Murine Metastatic Melanoma.Knockdown of NAT12/NAA30 reduces tumorigenic features of glioblastoma-initiating cells Development of a therapy against metastatic bladder cancer using an interleukin-2 surface-modified MB49 bladder cancer stem cells vaccine.Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells Prioritization schema for immunotherapy clinical trials in glioblastoma.Ultrasonic Surgical Aspirate is a Reliable Source For Culturing Glioblastoma Stem Cells.Immunotherapy with Dendritic Cells Modified with Tumor-Associated Antigen Gene Demonstrates Enhanced Antitumor Effect Against Lung Cancer Immunotherapy of cancer stem cells in solid tumors: initial findings and future prospective.New generation dendritic cell vaccine for immunotherapy of acute myeloid leukemia.mRNA-based dendritic cell vaccines.Active dendritic cell immunotherapy for glioblastoma: Current status and challenges.Glioblastoma stem cells and stem cell-targeting immunotherapies.Brain Tumor Immunotherapy: What have We Learned so Far?Immunotherapy with dendritic cells loaded with glioblastoma stem cells: from preclinical to clinical studies.Vaccination strategies for neuro-oncology.Cancer stem cell markers: premises and prospects.Immunomonitoring in glioma immunotherapy: current status and future perspectives.Exosomes as Tools to Suppress Primary Brain Tumor.Dendritic cell vaccines: A review of recent developments and their potential pediatric application.Dendritic cell vaccination for glioblastoma multiforme: review with focus on predictive factors for treatment response.The development of dendritic cell vaccine-based immunotherapies for glioblastoma.Isolation, identification, and characterization of cancer stem cells: A review.

P2860

Q26741736-2D3CF845-C1C2-4B2D-8637-49F01B57ED65 Q26744536-2414ACC4-6D78-4B2E-9D79-D252857FE53E Q26750765-077A94FF-AAF1-426C-945F-7A62CA34B23D Q26752558-DEA19C19-BBA3-454F-9CA2-04F67C8EA187 Q26776345-8A37050C-9080-48EA-B9C2-EF997001878C Q26781794-89B2E956-CA88-4703-82E1-35952ABBABB6 Q26783866-A63FD363-6BBC-4F85-8D5D-A94F884AC1F7 Q26861563-EF379FA3-52BA-48FE-9CA5-058D17B01A65 Q27002510-74DE233D-FF9D-47A8-8D92-FF8FA2356369 Q27014031-FBC117D5-09CF-4344-9473-7EFFAC9B101A Q27024047-A1011C96-6431-4184-A6CB-C546D3843FC5 Q28817010-02F75458-EA80-455E-8545-5F7F88C52F77 Q30875456-FBC56984-2D41-4601-A899-E482878EA86A Q33739733-DC8C65B0-2AB9-4498-A6DA-5D99E3D3D5DD Q35063763-016154E0-E600-4FD9-A136-5DC708AADE89 Q35114090-444365CC-0388-4588-86FC-D68FC3DFFBBB Q35529398-9D744064-001E-409C-BA9A-BB241DCF3852 Q35608944-46143ED2-6039-4CC5-A6B9-08BEE90371EB Q35761001-BF564D74-CC2F-419E-9D50-21CF4215F0B7 Q35986799-64D28082-9AE7-45B3-B128-A9DD1E81C784 Q36278425-06A6FE88-737E-4A07-A2B7-72DBDA989021 Q36413407-287A1205-ABCD-42FE-86DC-2808A27E61A2 Q37078999-80C637F3-0690-4355-B534-7BE7797CD7AC Q37239904-F93AAC1C-397D-4561-B915-BF6DDDF3F840 Q37606871-A3A8A716-0CCB-4C9E-AB71-F75277475B5C Q38212354-721C63C6-3641-4648-9695-5F56EFBAC50B Q38245928-E29FA5EC-4414-4CE4-A51C-E9F9C9283CBD Q38246769-4E11AFA1-3555-41B4-9223-D57BF80AFE73 Q38301084-73FB2B6E-420E-4948-BDF5-183A59ECA036 Q38355702-E3C34C09-38AB-48E6-8467-E6DAB41BA95F Q38542113-8404BA33-9A94-4872-BA86-BD3B1A882D3D Q38588141-EAEB4188-7E8F-4451-830E-81974F7F9565 Q38620079-9119CCA0-7EE3-47E7-BCD5-D423E04276FA Q38650088-167D369A-FE9A-4EEF-A067-3ABE166BF800 Q38659771-DC5A5BC7-CB3E-4402-9E4D-9DCBF3546C3C Q38777386-352C7026-A292-4C4C-BC1E-5786B43498E4 Q38849396-FC6CA1BF-25C8-4A77-BF9B-0A9F7E3FBF39 Q38912265-40F349DC-E155-4470-BA56-0CF91A95202F Q38990679-4B42AAA9-C1CD-42A4-9009-F6176CE4F01D Q39055537-4CE1CCDF-157B-45F4-B34F-BEEEC3E9A982

P2860

Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma.

http://www.wikidata.org/entity/Q37126620

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 02 July 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Therapeutic vaccination agains ...... in patients with glioblastoma.

@en

Therapeutic vaccination agains ...... in patients with glioblastoma.

@nl

type

label

Therapeutic vaccination agains ...... in patients with glioblastoma.

@en

Therapeutic vaccination agains ...... in patients with glioblastoma.

@nl

prefLabel

Therapeutic vaccination agains ...... in patients with glioblastoma.

@en

Therapeutic vaccination agains ...... in patients with glioblastoma.

@nl

P1433

Q37126620-140A4F0C-AB9B-4352-81C5-EB0F05B677D4

P1476

Q37126620-7D0BA005-9B4D-4AB7-B346-4BF47E7CE1A5

P2093

Q37126620-17962802-D502-4C24-8FC0-3210165020F8

Q37126620-27EF89B1-8060-4D80-A10E-5D443453C8CC

Q37126620-9776BAD0-3440-4F3E-84D8-79F7744644EB

Q37126620-9833E930-CB66-4682-95C9-8E9296A7FB83

Q37126620-A68871EE-A5D2-496F-B330-00B7D902E56B

Q37126620-AB76922C-6E85-4242-A005-E43F9051305A

Q37126620-BF7A19F4-3519-422F-884A-D504B8DD82AA

Q37126620-C9372E58-23A3-47D8-877A-84CF95809669

Q37126620-DAB7831A-6B97-44E1-93EF-B79A95CB0FA5

Q37126620-E6A88A78-D2A0-4442-8ABD-3FCC53A12A9D

P2860

Q37126620-01693A60-85F9-4306-AF9C-1887B7DF4F8A

Q37126620-2781AD16-BEA9-4061-95C2-5E18812A1098

Q37126620-2D9A4D4F-700C-494D-84EB-4475B2B66E79

Q37126620-350C288A-55A2-4F50-9B45-B2BCEEFAA426

Q37126620-3E3E372A-0F3A-4E8C-9EA6-D20BF6B5A8A3

Q37126620-4A83E5FC-5E8A-4DB1-9E29-904CED552CD8

Q37126620-55A4CE34-4335-4658-B87E-8169EE2CE898

Q37126620-574CF678-E06B-463B-9474-52E5DDA4EC7D

Q37126620-65A257D8-9612-43C7-B903-CC82D2E404AD

Q37126620-69B85440-E8CD-490F-9AA1-F55A3BE66313

P2888

Q37126620-84A9C808-5350-4221-A1A1-41166E2CE665

P304

Q37126620-8C919AC4-6DAF-4911-AC12-9398186361F0

P31

Q37126620-D084CA70-665B-4658-9828-4C61E9C99CBA

P356

Q37126620-1C8DF3B4-9638-40ED-9579-3443381DFA09

P433

Q37126620-06367A2B-ED73-4EEA-95A9-9FDF77AC0A26

P478

Q37126620-EF283105-CD6C-4988-9C8E-13F7C3CD2399

P50

Q37126620-1532E45C-4041-4E78-A792-3A662EE60DB6

Q37126620-5E7E87F6-6FF3-4F38-99CF-29FEA2E7BA2F

Q37126620-88166E5F-A02E-487C-AC1F-1CA6972A8966

Q37126620-A21027B4-EB07-47E9-8904-33EC95AC0788

P577

Q37126620-4D2D84A7-EC21-4987-A842-0DA834AE72EC

P5875

Q37126620-8B7F22DD-5E38-488E-B578-792EF7BE2F88

P698

Q37126620-93EFF5C7-633E-4134-B914-AB9BC2BAF3F5

P932

Q37126620-A8ECEB8C-8330-46E4-8931-B40CDD4CA15C

P356

S00262-013-1453-3

P1433

Cancer Immunology, Immunotherapy

P1476

Therapeutic vaccination agains ...... in patients with glioblastoma.

@en

P2093

Anne-Marie Rasmussen

http://www.w3.org/2001/XMLSchema#string

Birthe Viftrup Mikkelsen

http://www.w3.org/2001/XMLSchema#string

Cecilie Sandberg

http://www.w3.org/2001/XMLSchema#string

Else Marit Inderberg Suso

http://www.w3.org/2001/XMLSchema#string

Gunnar Kvalheim

http://www.w3.org/2001/XMLSchema#string

Jan E Brinchmann

http://www.w3.org/2001/XMLSchema#string

Knut Lote

http://www.w3.org/2001/XMLSchema#string

Marta Nyakas

http://www.w3.org/2001/XMLSchema#string

Morten Carstens Moe

http://www.w3.org/2001/XMLSchema#string

Paulina Due-Tønnesen

http://www.w3.org/2001/XMLSchema#string

P2860

Efficient tumour formation by single human melanoma cells

Immunotherapy with allotumour mRNA-transfected dendritic cells in androgen-resistant prostate cancer patients

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

Stem cells, cancer, and cancer stem cells

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Identification of a cancer stem cell in human brain tumors

Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro

Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma

Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system

P2888

s00262-013-1453-3

P304

1499-1509

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00262-013-1453-3

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

62

http://www.w3.org/2001/XMLSchema#string

P50

Gustav Gaudernack

Einar Osland Vik-Mo

Iver Arne Langmoen

P577

2013-07-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

244481819

http://www.w3.org/2001/XMLSchema#string

P698

23817721

http://www.w3.org/2001/XMLSchema#string

P932

3755221

http://www.w3.org/2001/XMLSchema#string